Gout Flares and Mortality After Sodium-Glucose Cotransporter-2 Inhibitor Treatment for Gout and Type 2 Diabetes

IMPORTANCE: Recurrent flares are the hallmark of clinical manifestation of gout. Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have been associated with a lower risk of incident gout; however, their association with recurrent flares is unknown. OBJECTIVE: To examine the association of SGLT2i vs...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jie, Choi, Hyon K., Dalbeth, Nicola, Li, Xiaoxiao, Li, Changjun, Zeng, Chao, Lei, Guanghua, Zhang, Yuqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457713/
https://www.ncbi.nlm.nih.gov/pubmed/37624597
http://dx.doi.org/10.1001/jamanetworkopen.2023.30885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457713/
https://www.ncbi.nlm.nih.gov/pubmed/37624597
http://dx.doi.org/10.1001/jamanetworkopen.2023.30885

Ejemplares similares